NAV logo

NAVCO Pharmaceuticals Inc. Stock Price

TSXV:NAV Community·CA$570.7k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NAV Share Price Performance

CA$0.01
0.01 (100.00%)
CA$0.01
0.01 (100.00%)
Price CA$0.01

NAV Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
1 Reward

NAVCO Pharmaceuticals Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$74.8k

Other Expenses

-CA$74.8k

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.0013
0%
0%
-8.1%
View Full Analysis

About NAV

Founded
n/a
Employees
n/a
CEO
Geoffrey Lee
WebsiteView website
navcopharma.com

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Recent NAV News & Updates

Recent updates

No updates